Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Etoposide Doxorubicin Cisplatin

Mixed Results for New Tx in Adrenal Cancer

Patients with advanced adrenocortical carcinoma lived no longer when standard therapy was combined with three-agent chemotherapy, but had a significantly higher response rate and progression-free survival (PFS), results of a large multicenter study showed.

Overall survival improved by almost 3 months with etoposide-doxorubicin-cisplatin (EDP) chemotherapy plus mitotane when compared with mitotane plus streptozocin, but… Mixed Results for New Tx in Adrenal Cancer   

cancerous prostate cells1 - university of calgary faculty of medicine1 - klotho hormone1 - renal carcinoma1 - ontario health insurance plan1 - computed tomography6 - urinary proteins2 - renal agenesis1 - adolescent obesity1 - ureter3 - bladder infections1 - subacute1 - clinical nephrology conference1 - hemodialysis therapy1 - psa velocity screening1 - university of michigan medical school in ann arbor1 - pubocervical fascia1 - autosomal-dominant polycystic kidney disease2 - severe urinary incontinence1 - fish1 - secondary prostate cancer1 - recurrent bladder infection1 - congenital malformations1 - hus1 - diagnostic test2 - crura1 - suburethral slings1 - urea1 - prostate-specific antigen screening1 - myelomatosis1 -